MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,985 | -58.7% | 3,476 | -8.0% | 0.00% | – |
Q1 2024 | $16,920 | +90.3% | 3,778 | -1.5% | 0.00% | – |
Q4 2023 | $8,891 | +78.5% | 3,835 | -2.3% | 0.00% | – |
Q3 2023 | $4,980 | -53.2% | 3,927 | +21.4% | 0.00% | – |
Q2 2023 | $10,637 | -20.0% | 3,235 | 0.0% | 0.00% | – |
Q1 2023 | $13,289 | -30.1% | 3,235 | 0.0% | 0.00% | – |
Q4 2022 | $19,000 | -13.6% | 3,235 | 0.0% | 0.00% | – |
Q3 2022 | $22,000 | +46.7% | 3,235 | 0.0% | 0.00% | – |
Q2 2022 | $15,000 | +25.0% | 3,235 | +3.8% | 0.00% | – |
Q1 2022 | $12,000 | +140.0% | 3,117 | +255.4% | 0.00% | – |
Q4 2021 | $5,000 | -37.5% | 877 | 0.0% | 0.00% | – |
Q3 2021 | $8,000 | -27.3% | 877 | +7.7% | 0.00% | – |
Q2 2021 | $11,000 | +120.0% | 814 | +189.7% | 0.00% | – |
Q1 2021 | $5,000 | +400.0% | 281 | +462.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | -66.7% | 50 | -88.9% | 0.00% | – |
Q1 2020 | $3,000 | – | 450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 818,033 | $14,144,000 | 22.27% |
ProQuest Associates IV LLC | 955,709 | $16,524,000 | 16.55% |
NEA Management Company, LLC | 8,144,267 | $140,814,000 | 4.93% |
Rock Springs Capital Management LP | 1,330,000 | $22,996,000 | 1.06% |
Cormorant Asset Management, LP | 295,549 | $5,110,000 | 0.90% |
ArrowMark Colorado Holdings LLC | 477,711 | $8,260,000 | 0.09% |
Spark Investment Management LLC | 18,688 | $323,000 | 0.02% |
WELLINGTON MANAGEMENT GROUP LLP | 2,391,404 | $41,348,000 | 0.01% |
TUDOR INVESTMENT CORP ET AL | 20,000 | $346,000 | 0.01% |
Laurion Capital Management LP | 50,000 | $865,000 | 0.00% |